Position in VCEL
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$3,200,915
-$382,080 QoQ
Shares Held
99,500
0.0% QoQ
Ownership
0.195%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swiss National Bank holds $1,640,558,253 across 148 Biotechnology names. VCEL ranks #72 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,600 | $332,493,684 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
303,140 | $234,218,089 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
387,720 | $128,284,916 | |
| 4 | INSM |
INSMED Inc
|
625,912 | $102,349,130 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,191,100 | $57,137,067 | |
| 6 | INCY |
Incyte Corp
|
489,774 | $46,097,528 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
425,431 | $41,373,164 | |
| 8 | MRNA |
Moderna, Inc.
|
696,100 | $35,361,880 |
All Filings in VCEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,200,915 | 99,500 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,582,995 | 99,500 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,071,472 | 97,600 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,072,035 | 95,700 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,270,134 | 95,700 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $5,298,815 | 96,500 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,819,400 | 90,400 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $4,147,552 | 90,400 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,655,790 | 89,500 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,172,851 | 89,100 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,328,536 | 99,300 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,685,617 | 98,100 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,691,576 | 91,800 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,699,850 | 102,500 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,333,920 | 100,600 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,500,374 | 99,300 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,592,680 | 94,000 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $3,423,030 | 87,100 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $4,250,480 | 87,100 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $4,520,250 | 86,100 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $4,905,065 | 88,300 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $2,686,560 | 87,000 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $1,699,201 | 91,700 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,247,946 | 90,300 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $754,691 | 82,300 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||